Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Piperlongumine Suppresses Growth and Sensitizes Pancreatic Tumors to Gemcitabine in a Xenograft Mouse Model by Modulating the NF-kappa B Pathway

Cancer Prev Res (Phila) (2016) 9 (3): 234–244.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Inhibition of the thioredoxin system for radiosensitization therapy of cancer
  • Yisheng Cao
  • Xiedong Zhou
  • Qiuying Nie
  • Junmin Zhang
European Journal of Medicinal Chemistry (2024) 268: 116218.
Delivery of piperlongumine via hyaluronic acid/phenylboronic acid-mediated dual targetable polymersome for enhanced anticancer functionality against pancreatic tumor
  • Ashok Kumar Jangid
  • Sungjun Kim
  • Kyobum Kim
International Journal of Biological Macromolecules (2024) 275: 133738.
Exploring aldose reductase inhibitors as promising therapeutic targets for diabetes-linked disabilities
  • Saheem Ahmad
  • Mohammad Faizan Ali Ahmad
  • Saif Khan
  • Sultan Alouffi
  • Mahvish Khan
  • Chander Prakash
  • Mohd Wajid Ali Khan
  • Irfan Ahmad Ansari
International Journal of Biological Macromolecules (2024) 280: 135761.
Phytochemicals for the prevention and treatment of pancreatic cancer: Current progress and future prospects
  • Nicolette Casarcia
  • Patrick Rogers
  • Emma Guld
  • Samvit Iyer
  • Yutong Li
  • Jack T. Burcher
  • Lindsay K. DeLiberto
  • Sabyasachi Banerjee
  • Anupam Bishayee
British Journal of Pharmacology (2023)
Umbelliprenin induces autophagy and apoptosis while inhibits cancer cell stemness in pancreatic cancer cells
  • Hongcheng Wang
  • Yongzhi Liu
  • Yiwei Wang
  • Ting Xu
  • Guanggai Xia
  • Xinyu Huang
Cancer Medicine (2023) 12 (14): 15277.
Therapeutic Approaches in Pancreatic Cancer: Recent Updates
  • Lokender Kumar
  • Sanjay Kumar
  • Kumar Sandeep
  • Sanjay Kumar Singh Patel
Biomedicines (2023) 11 (6): 1611.
Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy
  • Sajad Fakhri
  • Seyed Zachariah Moradi
  • Akram Yarmohammadi
  • Fatemeh Narimani
  • Carly E. Wallace
  • Anupam Bishayee
Frontiers in Oncology (2022) 12
Clinical Efficacy and Safety of Traditional Medicine Preparations Combined With Chemotherapy for Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
  • Jiaqi Hu
  • Juling Jiang
  • Rui Liu
  • Mengqi Cheng
  • Guanghui Zhu
  • Shulin He
  • Bolun Shi
  • Yuwei Zhao
  • Zhongning He
  • Huibo Yu
  • Xing Zhang
  • Honggang Zheng
  • Baojin Hua
Frontiers in Oncology (2022) 12
Piperlongumine induces ROS mediated apoptosis by transcriptional regulation of SMAD4/P21/P53 genes and synergizes with doxorubicin in osteosarcoma cells
  • Laxminarayan Rawat
  • Vijayashree Nayak
Chemico-Biological Interactions (2022) 354: 109832.
Piperlongumine inhibits the progression of osteosarcoma by downregulating the SOCS3/JAK2/STAT3 pathway via miR-30d-5p
  • Yawei Hu
  • Xinle Luo
  • Jianhua Zhou
  • Shaochu Chen
  • Ming Gong
  • Yue Deng
  • Hao Zhang
Life Sciences (2021) 277: 119501.
The promising potential of piperlongumine as an emerging therapeutics for cancer
  • Dey Parama
  • Varsha Rana
  • Sosmitha Girisa
  • Elika Verma
  • Uzini Devi Daimary
  • Krishan Kumar Thakur
  • Aviral Kumar
  • Ajaikumar B. Kunnumakkara
Exploration of Targeted Anti-tumor Therapy (2021)
Piperlongumine targets NF-κB and its downstream signaling pathways to suppress tumor growth and metastatic potential in experimental colon cancer
  • Sandeep Kumar
  • Navneet Agnihotri
Molecular and Cellular Biochemistry (2021) 476 (4): 1765.
Natural Products for Pancreatic Cancer Treatment: From Traditional Medicine to Modern Drug Discovery
  • Ahyeon Kim
  • Jiwon Ha
  • Jeongeun Kim
  • Yongmin Cho
  • Jimyung Ahn
  • Chunhoo Cheon
  • Sung-Hoon Kim
  • Seong-Gyu Ko
  • Bonglee Kim
Nutrients (2021) 13 (11): 3801.
Identification of Novel Drug Candidate for Epithelial Ovarian Cancer via In Silico Investigation and In Vitro Validation
  • Dan Zou
  • Jin Bai
  • Enting Lu
  • Chunjiao Yang
  • Jiaqing Liu
  • Zhenpeng Wen
  • Xuqin Liu
  • Zi Jin
  • Mengdan Xu
  • Lei Jiang
  • Ye Zhang
  • Yi Zhang
Frontiers in Oncology (2021) 11
RETRACTED: Resibufogenin suppresses growth and metastasis through inducing caspase‐1‐dependent pyroptosis via ROS‐mediated NF‐κB suppression in non‐small cell lung cancer
  • Hui Yin
  • Yan‐Ge Liu
  • Fei Li
  • Lun‐Qing Wang
  • Jian‐Hua Zha
  • Ying‐Chen Xia
  • Ben‐Tong Yu
  • Di‐Hao Wen
The Anatomical Record (2021) 304 (2): 302.
Piperlongumine promotes death of retinoblastoma cancer cells
  • Nathalie Allaman-Pillet
  • Daniel F. Schorderet
Oncotarget (2021) 12 (9): 907.
Synthesis, in vitro cytotoxicity, and molecular docking study of novel 3,4‐dihydroisoquinolin‐1(2H)‐one based piperlongumine analogues
  • Mahesh R. Kulkarni
  • Nitin P. Lad
  • Vijay M. Khedkar
  • Nitin D. Gaikwad
Journal of Heterocyclic Chemistry (2021) 58 (6): 1359.
A Derivative of Piperlongumine and Ligustrazine as a Potential Thioredoxin Reductase Inhibitor in Drug-Resistant Hepatocellular Carcinoma
  • Jianqiang Qian
  • Zhongyuan Xu
  • Peng Zhu
  • Chi Meng
  • Yun Liu
  • Wenpei Shan
  • Ang He
  • Yipeng Gu
  • Fansheng Ran
  • Yanan Zhang
  • Yong Ling
Journal of Natural Products (2021) 84 (12): 3161.
Protective Effect of Piplartine against LPS-Induced Sepsis through Attenuating the MAPKs/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation
  • Chi-Han Huang
  • Shu-Chi Wang
  • I-Chen Chen
  • Yi-Ting Chen
  • Po-Len Liu
  • Shih-Hua Fang
  • Shu-Pin Huang
  • Hsin-Chih Yeh
  • Ching-Chih Liu
  • Po-Yen Lee
  • Tzu-Chieh Lin
  • Wei-Chung Cheng
  • Chia-Cheng Su
  • Hsin-En Wu
  • Yuan-Ru Chen
  • Chia-Yang Li
Pharmaceuticals (2021) 14 (6): 588.
Deoxyelephantopin induces apoptosis via oxidative stress and enhances gemcitabine sensitivity in vitro and in vivo through targeting the NF-κB signaling pathway in pancreatic cancer
  • Daolin Ji
  • Xiangyu Zhong
  • Peng Huang
  • Pengcheng Kang
  • Kaiming Leng
  • Wangyang Zheng
  • Zhidong Wang
  • Yi Xu
  • Yunfu Cui
Aging (2020) 12 (11): 11116.
Two Natural Alkaloids Synergistically Induce Apoptosis in Breast Cancer Cells by Inhibiting STAT3 Activation
  • Di Chen
  • Yangmin Ma
  • Zhiyu Guo
  • Li Liu
  • Yaru Yang
  • Yuru Wang
  • Bonan Pan
  • Luyang Wu
  • Yuyu Hui
  • Wenjuan Yang
Molecules (2020) 25 (1): 216.
Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent
  • Surya Kant Tripathi
  • Bijesh Kumar Biswal
Pharmacological Research (2020) 156: 104772.
Effect of nanoemulsion modification with chitosan and sodium alginate on the topical delivery and efficacy of the cytotoxic agent piplartine in 2D and 3D skin cancer models
  • Daniela V. Giacone
  • Vanessa F.M.C. Dartora
  • Jenyffer K.R. de Matos
  • Julia S. Passos
  • Daniel A.G. Miranda
  • Erica A. de Oliveira
  • Edilberto R. Silveira
  • Leticia V. Costa-Lotufo
  • Silvya S. Maria-Engler
  • Luciana B. Lopes
International Journal of Biological Macromolecules (2020) 165: 1055.
Piperlongumine induces ROS mediated cell death and synergizes paclitaxel in human intestinal cancer cells
  • Laxminarayan Rawat
  • Harsha Hegde
  • Sugeerappa Laxmanappa Hoti
  • Vijayashree Nayak
Biomedicine & Pharmacotherapy (2020) 128: 110243.
Small Molecule Inhibitor C188-9 Synergistically Enhances the Demethylated Activity of Low-Dose 5-Aza-2′-Deoxycytidine Against Pancreatic Cancer
  • Rui Kong
  • Guangming Sun
  • Xina Li
  • Linfeng Wu
  • Le Li
  • Yilong Li
  • Fei Wang
  • Ping Xuan
  • Shifeng Yang
  • Bei Sun
  • Jisheng Hu
Frontiers in Oncology (2020) 10
Evaluation of chemo-diversity in major Piper species for three piperamides using validated RP-HPLC method
  • R. Sivaranjani
  • Johnson K. George
  • K. V. Saji
Genetic Resources and Crop Evolution (2019) 66 (8): 1635.
Piperlongumine increases sensitivity of colorectal cancer cells to radiation: Involvement of ROS production via dual inhibition of glutathione and thioredoxin systems
  • Hui Wang
  • Heng Jiang
  • Cyril Corbet
  • Sven de Mey
  • Kalun Law
  • Thierry Gevaert
  • Olivier Feron
  • Mark De Ridder
Cancer Letters (2019) 450: 42.
Activity-based protein profiling reveals GSTO1 as the covalent target of piperlongumine and a promising target for combination therapy for cancer
  • Li Li
  • Yue Zhao
  • Ran Cao
  • Lin Li
  • Gaihong Cai
  • Jiaojiao Li
  • Xiangbing Qi
  • She Chen
  • Zhiyuan Zhang
Chemical Communications (2019) 55 (30): 4407.
Synergistic anticancer activity of doxorubicin and piperlongumine on DU-145 prostate cancer cells – The involvement of carbonyl reductase 1 inhibition
  • Kamil Piska
  • Paulina Koczurkiewicz
  • Dawid Wnuk
  • Elżbieta Karnas
  • Adam Bucki
  • Katarzyna Wójcik-Pszczoła
  • Marek Jamrozik
  • Marta Michalik
  • Marcin Kołaczkowski
  • Elżbieta Pękala
Chemico-Biological Interactions (2019) 300: 40.
Piperlongumine analogue L50377 induces pyroptosis via ROS mediated NF-κB suppression in non-small-cell lung cancer
  • Qian Li
  • Liping Chen
  • Zhaojun Dong
  • Ya Zhao
  • Hui Deng
  • Jianzhang Wu
  • Xiaoping Wu
  • Wulan Li
Chemico-Biological Interactions (2019) 313: 108820.
Targeted therapies in pancreatic cancer: Promises and failures
  • Matineh Barati Bagherabad
  • Fahimeh Afzaljavan
  • Soodabeh ShahidSales
  • Seyed Mahdi Hassanian
  • Amir Avan
Journal of Cellular Biochemistry (2019) 120 (3): 2726.
Piperlongumine Induces Apoptosis and Synergizes with Doxorubicin by Inhibiting the JAK2-STAT3 Pathway in Triple-Negative Breast Cancer
  • Di Chen
  • Yangmin Ma
  • Peiqi Li
  • Meng Liu
  • Yuan Fang
  • Jiejie Zhang
  • Bilin Zhang
  • Yuyu Hui
  • Yue Yin
Molecules (2019) 24 (12): 2338.
Piperlongumine potentiates the effects of gemcitabine in in vitro and in vivo human pancreatic cancer models
  • Jiyan Mohammad
  • Harsharan Dhillon
  • Shireen Chikara
  • Sujan Mamidi
  • Avinash Sreedasyam
  • Kishore Chittem
  • Megan Orr
  • John C. Wilkinson
  • Katie M. Reindl
Oncotarget (2018) 9 (12): 10457.
Ethyl acetate fraction in ethanol extract from root of “Dai-Bai-Jie” (Marsdenia tenacissima): anti-tumor activity in A549 cancer cells
  • Li Xiaohua
  • Li Haitao
  • Jin Lingyu
  • Chen Leixi
  • Niu Yingfeng
  • Guan Yanhong
  • Ma Xiaojun
  • Zhang Lixia
Journal of Traditional Chinese Medicine (2018) 38 (5): 668.
Piperlongumine decreases cell proliferation and the expression of cell cycle-associated proteins by inhibiting Akt pathway in human lung cancer cells
  • Jin Sil Seok
  • Chang Hee Jeong
  • Michael C. Petriello
  • Han Geuk Seo
  • Hyunjin Yoo
  • Kwonho Hong
  • Sung Gu Han
Food and Chemical Toxicology (2018) 111: 9.
Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis
  • Yuki Yamaguchi
  • Takashi Kasukabe
  • Shunichi Kumakura
International Journal of Oncology (2018)
Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1
  • Wei Hang
  • Zhi-Xian Yin
  • Gang Liu
  • Qinghua Zeng
  • Xiang-Feng Shen
  • Qian-Hui Sun
  • Dong-Dong Li
  • Yong-Ping Jian
  • Yang-He Zhang
  • Yi-Shu Wang
  • Cheng-Shi Quan
  • Rui-Xun Zhao
  • Yu-Lin Li
  • Zhi-Xiang Xu
Oncogene (2018) 37 (25): 3384.
Novel piplartine-containing ruthenium complexes: synthesis, cell growth inhibition, apoptosis induction and ROS production on HCT116 cells
  • Cinara O. D’Sousa Costa
  • João H. Araujo Neto
  • Ingrid R.S. Baliza
  • Rosane B. Dias
  • Ludmila de F. Valverde
  • Manuela T.A. Vidal
  • Caroline B.S. Sales
  • Clarissa A.G. Rocha
  • Diogo R.M. Moreira
  • Milena B.P. Soares
  • Alzir A. Batista
  • Daniel P. Bezerra
Oncotarget (2017) 8 (61): 104367.
Piperlongumine (piplartine) and analogues: Antiproliferative microtubule-destabilising agents
  • Mary J. Meegan
  • Seema Nathwani
  • Brendan Twamley
  • Daniela M. Zisterer
  • Niamh M. O'Boyle
European Journal of Medicinal Chemistry (2017) 125: 453.
Natural Products as Adjunctive Treatment for Pancreatic Cancer: Recent Trends and Advancements
  • Qingxi Yue
  • Guogang Gao
  • Gangyong Zou
  • Haiqing Yu
  • Xi Zheng
BioMed Research International (2017) 2017: 1.
Discovery of piperlongumine as a potential novel lead for the development of senolytic agents
  • Yingying Wang
  • Jianhui Chang
  • Xingui Liu
  • Xuan Zhang
  • Suping Zhang
  • Xin Zhang
  • Daohong Zhou
  • Guangrong Zheng
Aging (2016) 8 (11): 2915.
  • Online ISSN 1940-6215
  • Print ISSN 1940-6207

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept